3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
12
Terminated
5
Unknown
2
Withdrawn
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
1
Fatigue
1
Cognitive Dysfunction
1
Interventions
Exercise
3
Cognitive Behavioral Therapy
3
Educational Status
2
enzalutamide
1
darolutamide
1
apalutamide
1
Testosterone
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Saline Solution
1
Radiotherapy
1
Quality of Life
1
Palliative Care
1
Neuropsychological Tests
1
Muscle Stretching Exercises
1
Modafinil
1
Methylphenidate
1
Methods
1
Mental Status and Dementia Tests
1
Melatonin
1
Laughter Therapy
1
Gels
1
Control Groups
1
Consolidation Chemotherapy
1
Chemoradiotherapy
1
Caregivers
1
Acupuncture, Ear
1
Acupressure
1
Acceptance and Commitment Therapy
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Fatigue
×
Modafinil
×
Clear all
NCT05333250
2026-01-13
MODIFY
Ottawa Hospital Research Institute
Phase 1/2
Recruiting
40 enrolled